Related references
Note: Only part of the references are listed.Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation
William Irish et al.
TRANSPLANTATION (2021)
Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation
Marc Raynaud et al.
KIDNEY INTERNATIONAL (2021)
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
Konstantin Doberer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation
Tracy J. Mayne et al.
CLINICAL TRANSPLANTATION (2021)
Long-Term Survival after Kidney Transplantation
Sundaram Hariharan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The evolution of histological changes suggestive of antibody-mediated injury, in the presence and absence of donor-specific anti-HLA antibodies
Maarten Coemans et al.
TRANSPLANT INTERNATIONAL (2021)
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Late Graft Loss After Kidney Transplantation: Is Death With Function Really Death With a Functioning Allograft?
Robert S. Gaston et al.
TRANSPLANTATION (2020)
Recurrence of FSGS after Kidney Transplantation in Adults
Audrey Uffing et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection
Alexandre Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Why Test for Proportional Hazards?
Mats J. Stensrud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The therapeutic challenge of late antibody-mediated kidney allograft rejection
Georg A. Boehmig et al.
TRANSPLANT INTERNATIONAL (2019)
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study
Alexandre Loupy et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants
Alice Koenig et al.
NATURE COMMUNICATIONS (2019)
An unjustified benefit: immortal time bias in the analysis of time-dependent events
Andreas Gleiss et al.
TRANSPLANT INTERNATIONAL (2018)
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial
Francesc Moreso et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes
Penelope J. Allen et al.
KIDNEY INTERNATIONAL (2017)
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
J. Choi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Relationship between eGFR Decline and Hard Outcomes after Kidney Transplants
Philip A. Clayton et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Recurrent IgA Nephropathy After Kidney Transplantation
S. Nijim et al.
TRANSPLANTATION PROCEEDINGS (2016)
Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Class II HLA Epitope Matching-A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
When do we need competing risks methods for survival analysis in nephrology?
Marlies Noordzij et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Summary of FDA Antibody-Mediated Rejection Workshop
P. Archdeacon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Pathological and Clinical Characterization of the 'Troubled Transplant': Data from the DeKAF Study
S. Gourishankar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
Andrew S. Levey et al.
CLINICAL CHEMISTRY (2007)
Share Paper
